New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 23, 2014
05:39 EDTRDYDr. Reddy's Labs announces launch of Fenofibrate capsules
Dr. Reddy’s Laboratories announced that it has launched Fenofibrate Capsules, USP 43 mg and 130 mg a therapeutic equivalent generic version of ANTARA capsules, in the US market on April 22, approved by the FDA.
News For RDY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 13, 2015
07:45 EDTRDYDr. Reddy's launches Memantine hydrochloride tablets, USP
Dr. Reddy's Laboratories announced that it has launched Memantine hydrochloride tablets USP, 5 mg and 10 mg, a therapeutic equivalent generic version of NAMENDA tablets in the US market on July 12, 2015, approved by the FDA. The NAMENDA tablets brand had U.S. sales of approximately $1.4B MAT for the most recent twelve months ending in May 2015 according to IMS Health. Dr. Reddy’s Memantine hydrochloride tablets USP, 5 mg is available in bottle count size of 60 and the Memantine hydrochloride tablets USP, 10 mg are available in bottle count sizes of 60 and 500.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use